Development of an in vitro miniature model to simulate immunoadsorption in patients with systemic lupus erythematosus

Journal of Clinical Apheresis

Volumn 17, Issue 4, 2002, Pages 183-189

  Avenhaus, Birgit ^a   Avenhaus, Wolfgang ^a   Schneider, Matthias ^b   Domschke, Wolfram ^a   Gaubitz, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anti cardiolipin antibodies; Anti dsDNA antibodies; Anti Ro (SSA) antibodies; ImmusorbaTM IMPH; Systemic lupus erythematosus; Therapeutic immunoadsorption

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RO ANTIBODY; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BIOLOGICAL MODEL; BLOOD FLOW; CONTROLLED STUDY; DEVICE; HUMAN; IMMUNOADSORPTION; IN VITRO STUDY; LIGAND BINDING; PLASMA PROTEIN BINDING; SIMULATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSORBENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, BIOLOGICAL;

EID: 0036916692     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10034     Document Type: Article

References (29)

1. Jones JV, Cumming RH, Bacon PA, et al. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q J Med 1979;48:555-576.
2. Derksen RHWM, Hene RJ, Kallenberg CG, Valentijn RM, Kater L. Prospective multicenter trial on th short-term effects of plasmapheresis versus cytotoxic drugs in steroid-resistant lupus nephritis. Neth J Med 1988;33:168-177.
3. Euler HH, Schröder JO, Harten P, Zeuner RA, Gutschmidt HJ. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 1994; 37:1784-1794.
4. French Cooperative Study Group. A randomized trial of plasma exchange in severe acute lupus erythematosus: Methodology and interim analysis. Plasma Ther Trans Tech 1985;6:535-539.
5. Lewis EJ, Hunsicker LG, Lan S-P, Rhode RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992;326:1373-1389.
6. Wallace DJ, Goldfinger D, Nichols S, et al. A controlled study on the use of plasmapheresis in steroid/immunosuppressive resistant systemic lupus erythematosus with nephrotic syndrome. In: Oda T, Shiokawa Y, Inoue N, editors. Proceedings of the First International Congress of the World Apheresis Association: Therapeutic Plasmapheresis VI. Cleveland: ISAO Press; 1987. p 91-102.
7. Wei N, Klippel JH, Huston DP, et al. Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1983;1:17-22.
8. Schneider M, Berning T, Waldendorf M, Glaser J, Gerlach U. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus. J Rheumatol 1990;17:900-907.
9. Palmer A, Gjorstrup P, Severn A, Welsh K, Taube D. Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption (letter). Lancet 1988;11:272.
10. Hiepe F, Pfuller B, Wolbart K, Bruns A, Leinenbach HP, Hepper M, Schossler W, Otto V. C1q: A multifunctional ligand for a new immunoadsorption treatment. Ther Apher 1999; 3:246-251.
11. Suzuki K, Hara M, Harigai M, et al. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus. Arthritis Rheum 1991;34:1546-1552.
12. Gaubitz M, Seidel M, Kummer S, Schotte H, Perniok A, Domschke W, Schneider M. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus. J Autoimmun 1998;11:495-501.
13. Ikonomov V, Samtleben W, Schmidt B, Blumenstein M, Gurland HJ. Adsorption profile of commercially available adsorbents: An in vitro evaluation. Int J Artif Organs 1992; 15:312-319.
14. Matsuki Y, Suzuki K, Kawakami M, Ishizuka T, Kawaguchi Y, Hidaka T, Nakamura H. High-avidity anti-DNA-antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns. J Clin Apheresis 1996;11:30-35.
15. Yamazaki Z, Idezuki Y, Inone N, et al. Extracorporeal immunoadsorption with IM-PH or IM-TR column. Biomater Artif Cells Artif Organs 1989;17:117-124.
16. Yamazaki Z, Fujimori Y, Takahama T, et al. Efficiency and biocompatibility of a new immunoadsorbent. Trans Am Soc Artif Intern Organs 1982;28:318-323.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
18. Waldendorf M, Schneider M, Krummenerl T, Gerlach U. Experimentelle und klinische untersuchungen zur immunadsorption bei patienten mit systemischem lupus erythematodes. Z Rheumatol 1986;45:189.
19. Okudaira K, Kobayashi N, Yoshizawa H. Effect of immunoadsorbent treatment on auto-antibody levels. In: Oda T, editor. Therapeutic Plasmapheresis IV. Stuttgart New York: Schattauer. 1984. p 149-152.
20. Kinoshita M, Aotsuka S, Funahashi T, Tani N, Yokohari R. Selective removal of anti-double-stranded DNA antibodies by immunoadsorption with dextran sulphate in a patient with systemic lupus erythematosus. Ann Rheum Dis 1989;48:856-860.
21. Yamazaki Z, Fujimori Y, Iizoka I, et al. Immunoadsorbent plasma perfusion in patients with rheumatoid arthritis or systemic lupus erythematosus. Prog Artif Organs 1983;708-712.
22. Usuda M, Maeda K, Sezaki R, et al. Clinical application of newly developed adsorbent resin (I-02) for the regeneration of plasma from auto-immune disease patients. In: Oda T, editors. Therapeutic Plasmapheresis II. Stuttgart, New York: Schattauer, 1982. p 105-110.
23. Heininger K, Toyka KV, Gaczkowski A, Hartung HP, Borberg H, Grabensee B. Selective removal of pathogenic factors in neurologic diseases. Plasma Ther Transfus Technol 1986; 7:351-357.
24. Tsuruta Y, Maeda K, Shinazato T, et al. In vitro evaluation of a sorbent with tryptophan and phenylalanine as ligands. In: Oda T, editor. Therapeutic Plasmapheresis IV. Stuttgart, New York: Schattauer; 1984. p 159-163.
25. Hashimoto H, Tsuda H, Kanai Y, et al. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextrane sulfate columns in patients with systemic lupus erythematosus. J Rheumatol 1991;18:545-551.
26. Maeshima E, Yamada Y, Kodama N, Mune M, Yukawa S. Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A. Scand J Rheumatol 1999;28:54-57.
27. Nakamura Y, Yoshida K, Itoh S, Kanai Y, Tsuda H, Hashimoto H, Mitsuhashi N, Kuwabara Y. Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies. Am J Reprod Immunol 1999;41:307-311.
28. Hara S, Yokoyama K, Maehara S, et al. Immunoadsorption and plasmapheresis for habitual premature delivery: A case with anti RNP and SS-A antibodies. Jpn J Apheresis 1997; 16:181-182.
29. Tsuruta Y, Maeda K, Shinazato T, et al. Treatment of SLE and RA with a new immunoadsorbent. In: Oda T, editor. Therapeutic Plasmapheresis III. Stuttgart, New York: Schattauer; 1983. p 241-245.